At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DNA Ginkgo Bioworks Holdings Inc.
Market Closed 03-13 16:00:00 EDT
6.80
+0.40
+6.25%
盘后6.81
+0.01+0.12%
19:59 EDT
High7.06Low6.43Vol1.76M
Open6.43D1 Closing6.40Amplitude9.84%
Mkt Cap421.09MTradable Cap282.45MTotal Shares61.92M
T/O12.02MT/O Rate4.23%Tradable Shares41.54M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Lucence, DxD Hub and NCCS launch $6 mil cancer diagnostics research collaboration
Nurdianah Md Nur  ·  03-13 05:11
Lucence, DxD Hub and NCCS launch $6 mil cancer diagnostics research collaboration
Ginkgo Bioworks Holdings Is Maintained at Sell by BTIG
Dow Jones  ·  03-12 19:21
Ginkgo Bioworks Holdings Is Maintained at Sell by BTIG
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen
Benzinga_recent_news  ·  03-08
Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen
AKESO Shares Surge Over 6% in Morning Session on Novel Brain Cancer Treatment Collaboration
Stock News  ·  03-05
AKESO Shares Surge Over 6% in Morning Session on Novel Brain Cancer Treatment Collaboration
4basebio bolsters commercial leadership to drive synthetic DNA growth
TIPRANKS  ·  03-03
4basebio bolsters commercial leadership to drive synthetic DNA growth
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers
MT Newswires Live  ·  03-02
Ginkgo Bioworks Launches Ginkgo Cloud Lab to Provide Remote Access for Researchers
A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture
Simply Wall St.  ·  03-02
A Look At Ginkgo Bioworks (DNA) Valuation As It Pivots To Robotics Labs And Biosecurity Divestiture
Ginkgo Bioworks posts fall in Q4 revenue; co to divest biosecurity business
Reuters  ·  02-27
Ginkgo Bioworks posts fall in Q4 revenue; co to divest biosecurity business
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Benzinga  ·  02-27
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Ginkgo Bioworks Holdings Inc: Deal in Exchange for a Minority Equity Position in Biosecurity Business Alongside Investors
THOMSON REUTERS  ·  02-27
Ginkgo Bioworks Holdings Inc: Deal in Exchange for a Minority Equity Position in Biosecurity Business Alongside Investors
Ginkgo Bioworks Q4 Net Income USD -81 Million
THOMSON REUTERS  ·  02-27
Ginkgo Bioworks Q4 Net Income USD -81 Million
Press Release: Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Dow Jones  ·  02-27
Press Release: Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
Ginkgo Bioworks Holdings Inc. published an update to their financial calendar
Reuters  ·  02-19
Ginkgo Bioworks Holdings Inc. published an update to their financial calendar
Ginkgo Bioworks and Invaio Sciences partner to develop peptide crop protection manufacturing strains
Reuters  ·  02-18
Ginkgo Bioworks and Invaio Sciences partner to develop peptide crop protection manufacturing strains
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-Based Agricultural Products
THOMSON REUTERS  ·  02-18
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-Based Agricultural Products
Deep Analysis | The Ingrained Cultural Imperative of Chinese New Year Homecomings
Deep News  ·  02-15
Deep Analysis | The Ingrained Cultural Imperative of Chinese New Year Homecomings
Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth
GlobeNewswire  ·  02-12
Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth
4basebio Directors Lift Stakes in Synthetic DNA Specialist
TIPRANKS  ·  02-12
4basebio Directors Lift Stakes in Synthetic DNA Specialist
The Safety DNA: Decoding UL 9540B's Unseen Protections
prnewswire  ·  02-11
The Safety DNA: Decoding UL 9540B's Unseen Protections
Ginkgo Bioworks jumps after OpenAI comment on working together
TIPRANKS  ·  02-06
Ginkgo Bioworks jumps after OpenAI comment on working together

Introduction

Company Name.
Ginkgo Bioworks Holdings Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Issue price:
--